Tranexamic Acid Dosing in Adult Spinal Deformity Surgery
Status:
Active, not recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate two dosing protocols for tranexamic acid (TXA), an
anti-fibrinolytic used to decrease blood loss in adult patients undergoing complex,
reconstructive spinal fusion surgeries.